COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1553: Articles 15521-15530  | Next

The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients.
Caruana, G., Lebrun, L.-L., Aebischer, O., Opota, O., Urbano, L., DeRham, M., Marchetti, O., Greub, G.
10.1101/2021.04.24.21256040 — Posted: 2021-04-27
Clinical validation of RCSMS: a rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva
Abugattas Nunez del Prado, J., Quintana Reyes, A., Blume La Torre, J., Gutierrez Loli, R., Pinzon Olejua, A., Chamorro Chirinos, E., Loza Mauricio, F. A., Maguina, J. L., Leon, J., Rodriguez-Aliaga, P., Málaga-Trillo, E.
10.1101/2021.04.26.21256081 — Posted: 2021-04-27
Rapid structure-function insights via hairpin-centric analysis of big RNA structure probing datasets
Radecki, P., Uppuluri, R., Aviran, S.
10.1101/2021.04.27.441661 — Posted: 2021-04-27
Aerosol Exposure of Cynomolgus Macaques to SARS-CoV-2 Results in More Severe Pathology than Existing Models
Bixler, S. L., Stefan, C. P., Jay, A., Rossi, F. D., Ricks, K. M., Shoemaker, C. J., Moreau, A. M., Zeng, X., Hooper, J., Dyer, D., Frick, O., Koehler, J. W., Kearney, B., DiPinto, N., Liu, J., Tostenson, S., Clements, T. L., Smith, J. M., Johnson, J. A., Berrier, K., Esham, H., Delp, K. L., Coyne, S. R., Bloomfield, H., Kuehnert, P., Akers, K., Gibson, K., Minogue, T., Nalca, A., Pitt, M. L. M.
10.1101/2021.04.27.441510 — Posted: 2021-04-27
How the COVID-19 pandemic is shaping research in Africa: inequalities in scholarly output and collaborations and new opportunities for scientific leadership
Mbogning Fonkou, M. D., Bragazzi, N. L., Tsinda, E. K., Bouba, Y., Mmbando, G. S., Kong, J. D.
10.1101/2021.04.24.21256053 — Posted: 2021-04-27
Miami-Dade: A Case Study of Domestic Violence Arrests During the COVID-19 Pandemic
Kurland, J., Piquero, A. R., Leeper Piquero, N.
10.1101/2021.04.20.21255830 — Posted: 2021-04-27
The SARS-CoV2 pandemic explained via asymptomatic infection and susceptibility heterogeneity. Buenos Aires First Wave
Bullo, M., Poy Pineiro, S., Cosatto, P., Seoane, H., Picasso, E.
10.1101/2021.04.26.21255801 — Posted: 2021-04-27
COVID-19 vaccine acceptance in older Syrian refugees: preliminary findings from an ongoing study
El Salibi, N., Abdulrahim, S., El Haddad, M., Bassil, S., El Khoury, Z., Ghattas, H., McCall, S.
10.1101/2021.04.25.21256024 — Posted: 2021-04-27
Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data
Durant, T. J., Koch, C. D., Kerantzas, C. A., Peaper, D. R.
10.1101/2021.04.26.21254638 — Posted: 2021-04-27
It's complicated: characterizing the time-varying relationship between cell phone mobility and COVID-19 spread in the US
Jewell, S., Futoma, J., Hannah, L., Miller, A., Foti, N., Fox, E.
10.1101/2021.04.24.21255827 — Posted: 2021-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).